SlideShare a Scribd company logo
Tom O’Connor  Julia Walker  Lauren Dusak  Kristina Gentilozzi  Kaitlin McQuade  Frank Marallo  Derek Szu-Tu  Lauren Faga  Brandon Miniman  Sean Helmig  Carolyn McCarthy  Chuck Sgammato  Mike Pattavina  Angela Russo  M ax1m  I nnovations
Our Product ,[object Object],[object Object],[object Object],[object Object],Maxim  Innovations
Benefits of Vitamin B12   ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Maxim  Innovations
Why Put B12 in a Chewing Gum? ,[object Object],[object Object],[object Object],[object Object],[object Object],Maxim  Innovations
Vitamin Market ,[object Object],[object Object],[object Object],[object Object],Maxim  Innovations
Target  Market & Market Share ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Maxim  Innovations 4.9% 5,729,729 5 4.4% 5,202,048 4 3.8% 4,523,520 3 3.2% 3,769,600 2 1.6% 1,884,800 1 Market Share People Year
Distribution ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Maxim  Innovations
Promotion ,[object Object],[object Object],[object Object],[object Object],Maxim  Innovations 16.8 Self 23.4 Sports Illustrated 19.2 Shape 6.5 Men's Fitness 7.5 Women's Health 17.5 Men's Health Circulation (millions) Magazine
SWOT Analysis Maxim  Innovations ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
CM and Net Income Wholesale Price:  $1.59 Cost:  -  $0.14 Contribution Margin:  $1.45 Projected Net Income Contribution Margin Maxim  Innovations
Break Even Maxim  Innovations
What the Future Holds Maxim  Innovations ,[object Object],[object Object],[object Object],[object Object],In Seven Years…
Why are there no other vitamins in Boost 12? ,[object Object],[object Object],[object Object],Maxim  Innovations
Chewing Gum Manufacturers ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Maxim  Innovations
Vitamin B12 Suppliers ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Maxim  Innovations
Common Side Effects of Caffeine ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Maxim  Innovations
Existings Products **** It is a proven fact that Vitamin B12’s absorption is inhibited by certain vitamins, including Vitamin C, 1 of the 10 essential vitamins found in Vitaball Purpose: Distribution: Target Market: Maxim  Innovations Energy Seeking Adults! Children Sticks Gumballs Delivers Vitamin B12 to promotes the production of red blood cells, increased metabolism and more ENERGY Delivers 100% Recommended Daily Allowance of 10 essential vitamins Boost 12 Vitaball
Vitamin B12 Absorption Through Tongue According to the article,  Vitamin B12 Cobalamin , sublingual (under the tongue) delivery of Vitamin B12, such as through a gum or tablet form, is most effective.  This method of delivery allows the for the quickest way for B12 to be absorbed straight into the bloodstream. Maxim  Innovations
Functional Gum Market “ Wrigley, Cadbury and Hershey all continue to take steps in new product development …. If a smaller company develops a functional gum type that is able to challenge the existing hierarchy of teeth whitening gums, it is likely that they would make an attractive target to one of these larger players.”  Quote on www.gmid.euromonitor.com.  Maxim  Innovations
Taste Preference Maxim  Innovations Source: Euromonitor International estimates 10.00 10.00 10.00 Lemon  9.00 9.00 9.00 Apple  7.00 7.00 7.00 Juicy Fruit  6.00 6.00 6.00 Cinnamon  5.00 4.00 4.00 Wintergreen  4.00 5.00 5.00 Bubble Gum  3.00 3.00 3.00 Mint  2.00 2.00 2.00 Peppermint  1.00 1.00 1.00 Spearmint  2006 2005 2004 Rank Table 7 Leading Flavors for Gum 2004-2006
Have you had your B12 today? Recommended Dietary Allowances for Vitamin B12 Source: www.ods.od.nih.gov Maxim  Innovations 2.4 19+ 2.4 14-18 1.8 9-13 1.2 4-8 0.9 1-3 Allowance (μg/day) Age (years)
Patent Pricing ,[object Object],[object Object],[object Object],Application Fee  $300 Search Fee $500 Examination Fee  $200 Post-Allowance Fee $1,400 International filing Fee  $1,086 International Search Fee  $2,059 Lawyer  $2000  Initial Filing Fee $750 $8,295 TOTAL Maxim  Innovations
[object Object],[object Object],[object Object],[object Object],[object Object],Why is Boost 12 priced $1.99? Maxim  Innovations
Ad Cost per year   Rate Base per year Men’s Fitness  668,360  6,500,000 Men’s Health  1,461,600  17,500,000 Women’s Health  834,756  7,500,000 Shape  1,202,640   19,200,000 Total  $ 4,167,356  50,700,000  Yr 1  Sports Illustrated  2,222,755  23,400,000 Self  1,230,636  16,800,000 4,167,356   50,700,000 Total  $ 7,620,747  90,900,000   Yr 2 Magazine Advertising Costs Maxim  Innovations
Other Advertising Costs ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Maxim  Innovations
Year One:  $4,294,377 Year Two:  $7,767,665 Year Three:  $8,136,182 Year Four:  $8,494,800 Year Five:  $8,494,800 Total Advertising Costs Per Year Maxim  Innovations
Valuation of Company Residual Value $16,093,533 NPV $9,093,533 Projected Sales Price $25,187,066 Maxim  Innovations
Break Even (10% increase best case) Maxim  Innovations
Projected Income (10% sales increase) NPV = $14,419,233 IRR = 38% Maxim  Innovations
Sales Figures (Expected) Maxim  Innovations 305,772  552 46 5322 Total 19,944  72 6 277 Trader Joes 17,616  48 4 367 Bally 6,480  48 4 135 Sports Clubs  24,000  60 5 400 LA Fitness 25,536  48 4 532 Gold's Gym 8,592  48 4 179 World Gym 9,264  48 4 193 Whole Foods 33,000  60 5 550 Vitamin Works 9,600  60 5 160 Vitamin Shoppe 151,740  60 5 2529 GNC Stores Total # boxes # boxes/ yr # boxes /  month # Stores YEAR 2008
Sales Figures (Expected Cont.) ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Maxim  Innovations
Sales Forecast (Worst 10% decrease) ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Maxim  Innovations
Sales Forecast (Best 5% increase) ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Maxim  Innovations
Taxes (Expected) Maxim  Innovations $  4,514,224  $  3,423,476  $  2,479,680  $  913,079  $  (509,131) $  (773,755) $  -  Tax Payable $  -  $  -  $  -  $  913,079  $  (509,131) $  (890,137) $  (773,755) Total NOL $  4,514,224  $  3,423,476  $  2,479,680  $  1,422,210  $  381,006  $  -  $  -  Income Tax Expense $  -  $  -  $  -  $  -  $  -  $  (116,382) $  (773,755) NOL $  4,514,224  $  3,423,476  $  2,479,680  $  1,422,210  $  381,006  $  (116,382) $  (773,755) Tax Expense $  13,277,129  $  10,069,046  $  7,293,175  $  4,182,971  $  1,120,606  $  (342,301) $  (2,275,749) Earnings before Taxes 2014 2013 2012 2011 2010 2009 2008
Taxes (Worst Case) Maxim  Innovations $  3,634,959  $  2,658,897  $  1,306,256  $  (508,573) $  (1,376,741) $  (912,784) $  -  Tax Pay $  -  $  -  $  1,306,256  $  (508,573) $  (1,376,741) $  (1,376,741) $  (912,784) Total NOL $  3,634,959  $  2,658,897  $  1,814,829  $  868,168  $  -  $  -  $  -  Income Tax Exp $  -  $  -  $  -  $  -  $  (36,083) $  (463,957) $  (912,784) NOL $  3,634,959  $  2,658,897  $  1,814,829  $  868,168  $  (36,083) $  (463,957) $  (912,784) Tax Exp $  10,691,055  $  7,820,286  $  5,337,732  $  2,553,435  $  (106,125) $  (1,364,578) $  (2,684,659) EBIT 2014 2013 2012 2011 2010 2009 2008
Taxes (Best Case) Maxim  Innovations $  4,954,752  $  3,806,205  $ 2,812,105  $ 1,641,947  $  (57,285) $ (646,835) $  -  Tax Payable $  -  $  -  $  -  $ 1,641,947  $  (57,285) $ (646,835) $  (704,240) Total NOL $  4,954,752  $  3,806,205  $ 2,812,105  $ 1,699,231  $  589,551  $  57,405  $  -  Income Tax Expense $  -  $  -  $  -  $  -  $  -  $  -  $  (704,240) NOL $  4,954,752  $  3,806,205  $ 2,812,105  $ 1,699,231  $  589,551  $  57,405  $  (704,240) Tax Expense $ 14,572,800  $ 11,194,721  $ 8,270,897  $ 4,997,739  $ 1,733,972  $  168,837  $ (2,071,293) Earnings before Taxes 2014 2013 2012 2011 2010 2009 2008

More Related Content

Viewers also liked

The World’s Most Reputable Countries 2012
The World’s Most Reputable Countries 2012The World’s Most Reputable Countries 2012
The World’s Most Reputable Countries 2012
Aleksey Chuiev
 
Operational Space
Operational SpaceOperational Space
Operational Space
Larry Roeder
 
Leveraging LinkedIn
Leveraging LinkedIn Leveraging LinkedIn
Leveraging LinkedIn
Aaron Downes
 
BUSINESS, Special Issue (Cherkasy region), 2015
BUSINESS, Special Issue (Cherkasy region), 2015BUSINESS, Special Issue (Cherkasy region), 2015
BUSINESS, Special Issue (Cherkasy region), 2015
Aleksey Chuiev
 
Speak Up presentation, rus
Speak Up presentation, rusSpeak Up presentation, rus
Speak Up presentation, rusAleksey Chuiev
 
LinkedIn Follower ecosystem
LinkedIn Follower ecosystem LinkedIn Follower ecosystem
LinkedIn Follower ecosystem
Aaron Downes
 
Protectinganimalsfromdisaster4
Protectinganimalsfromdisaster4Protectinganimalsfromdisaster4
Protectinganimalsfromdisaster4
Larry Roeder
 
Notes for Speech by Larry Roeder
Notes for Speech by Larry RoederNotes for Speech by Larry Roeder
Notes for Speech by Larry Roeder
Larry Roeder
 
German familyphotoalbum2
German familyphotoalbum2German familyphotoalbum2
German familyphotoalbum2
Larry Roeder
 
Missions at the UN
Missions at the UNMissions at the UN
Missions at the UN
Larry Roeder
 
Learning And Memory Geico2
Learning And Memory  Geico2Learning And Memory  Geico2
Learning And Memory Geico2
Kmcqua01
 
Livre blanc Rubedo CMS 3.x
Livre blanc Rubedo CMS 3.xLivre blanc Rubedo CMS 3.x
Livre blanc Rubedo CMS 3.x
Rubedo, a WebTales solution
 
Lediscoursrapportindirect
LediscoursrapportindirectLediscoursrapportindirect
Lediscoursrapportindirect
Patricia Álvarez Sánchez
 
L'art d'être parent à l'ère numérique
L'art d'être parent à l'ère numériqueL'art d'être parent à l'ère numérique
L'art d'être parent à l'ère numérique
MediaSmarts | HabiloMédias
 
Utiliser Twitter pour developper votre visibilite sur le web
Utiliser Twitter pour developper votre visibilite sur le webUtiliser Twitter pour developper votre visibilite sur le web
Utiliser Twitter pour developper votre visibilite sur le web
WSIdee
 
Catalogue de nos formation auprès des elus janvier 2013
Catalogue de nos formation auprès des elus  janvier 2013Catalogue de nos formation auprès des elus  janvier 2013
Catalogue de nos formation auprès des elus janvier 2013
Julien Voyez
 
Workshop Springer - Tunisia
Workshop Springer - TunisiaWorkshop Springer - Tunisia
Workshop Springer - Tunisia
Bessem Aamira
 
Devoirs Algorithme + correction pour 4 si
Devoirs Algorithme + correction pour 4 siDevoirs Algorithme + correction pour 4 si
Devoirs Algorithme + correction pour 4 siNarûtö Bàl'Sèm
 
E portfolio hesso-fribourg-journee2-13-10-14
E portfolio hesso-fribourg-journee2-13-10-14E portfolio hesso-fribourg-journee2-13-10-14
E portfolio hesso-fribourg-journee2-13-10-14
Dominique-Alain JAN
 

Viewers also liked (19)

The World’s Most Reputable Countries 2012
The World’s Most Reputable Countries 2012The World’s Most Reputable Countries 2012
The World’s Most Reputable Countries 2012
 
Operational Space
Operational SpaceOperational Space
Operational Space
 
Leveraging LinkedIn
Leveraging LinkedIn Leveraging LinkedIn
Leveraging LinkedIn
 
BUSINESS, Special Issue (Cherkasy region), 2015
BUSINESS, Special Issue (Cherkasy region), 2015BUSINESS, Special Issue (Cherkasy region), 2015
BUSINESS, Special Issue (Cherkasy region), 2015
 
Speak Up presentation, rus
Speak Up presentation, rusSpeak Up presentation, rus
Speak Up presentation, rus
 
LinkedIn Follower ecosystem
LinkedIn Follower ecosystem LinkedIn Follower ecosystem
LinkedIn Follower ecosystem
 
Protectinganimalsfromdisaster4
Protectinganimalsfromdisaster4Protectinganimalsfromdisaster4
Protectinganimalsfromdisaster4
 
Notes for Speech by Larry Roeder
Notes for Speech by Larry RoederNotes for Speech by Larry Roeder
Notes for Speech by Larry Roeder
 
German familyphotoalbum2
German familyphotoalbum2German familyphotoalbum2
German familyphotoalbum2
 
Missions at the UN
Missions at the UNMissions at the UN
Missions at the UN
 
Learning And Memory Geico2
Learning And Memory  Geico2Learning And Memory  Geico2
Learning And Memory Geico2
 
Livre blanc Rubedo CMS 3.x
Livre blanc Rubedo CMS 3.xLivre blanc Rubedo CMS 3.x
Livre blanc Rubedo CMS 3.x
 
Lediscoursrapportindirect
LediscoursrapportindirectLediscoursrapportindirect
Lediscoursrapportindirect
 
L'art d'être parent à l'ère numérique
L'art d'être parent à l'ère numériqueL'art d'être parent à l'ère numérique
L'art d'être parent à l'ère numérique
 
Utiliser Twitter pour developper votre visibilite sur le web
Utiliser Twitter pour developper votre visibilite sur le webUtiliser Twitter pour developper votre visibilite sur le web
Utiliser Twitter pour developper votre visibilite sur le web
 
Catalogue de nos formation auprès des elus janvier 2013
Catalogue de nos formation auprès des elus  janvier 2013Catalogue de nos formation auprès des elus  janvier 2013
Catalogue de nos formation auprès des elus janvier 2013
 
Workshop Springer - Tunisia
Workshop Springer - TunisiaWorkshop Springer - Tunisia
Workshop Springer - Tunisia
 
Devoirs Algorithme + correction pour 4 si
Devoirs Algorithme + correction pour 4 siDevoirs Algorithme + correction pour 4 si
Devoirs Algorithme + correction pour 4 si
 
E portfolio hesso-fribourg-journee2-13-10-14
E portfolio hesso-fribourg-journee2-13-10-14E portfolio hesso-fribourg-journee2-13-10-14
E portfolio hesso-fribourg-journee2-13-10-14
 

Similar to Max1m 1230 042507

Freedom Plan 5[1]
Freedom Plan 5[1]Freedom Plan 5[1]
Freedom Plan 5[1]
suzankreed
 
Agel Presentation
Agel PresentationAgel Presentation
Agel Presentation
ChristineToomey
 
Agel Updated Abb Ppt 11 17 08
Agel Updated Abb Ppt 11 17 08Agel Updated Abb Ppt 11 17 08
Agel Updated Abb Ppt 11 17 08
TiffanyHodge
 
Agel Business Briefing
Agel Business BriefingAgel Business Briefing
Agel Business Briefing
Melvin Muhammad
 
Abb Presentation
Abb PresentationAbb Presentation
Abb Presentation
Rico Gutierrez
 
New Company Launches
New Company LaunchesNew Company Launches
New Company Launches
lisaseto
 
Agel Presentation 20090521
Agel Presentation 20090521Agel Presentation 20090521
Agel Presentation 20090521
ericfoinquinos
 
Traci's vs. new team elites ppt aug 2011
Traci's vs. new team elites ppt aug 2011 Traci's vs. new team elites ppt aug 2011
Traci's vs. new team elites ppt aug 2011
John Wright
 
NuCERITY International Pre-Launch Opportunity
NuCERITY International Pre-Launch OpportunityNuCERITY International Pre-Launch Opportunity
NuCERITY International Pre-Launch Opportunity
NuCERITY International
 
Nucerity International Business Opportunity
Nucerity International  Business OpportunityNucerity International  Business Opportunity
Nucerity International Business Opportunity
qosheba915
 
NuCERITY International Pre-Launch Opportunity
NuCERITY International Pre-Launch OpportunityNuCERITY International Pre-Launch Opportunity
NuCERITY International Pre-Launch Opportunity
NuCERITY International
 
NuCerity New Opportunity Meeting
NuCerity New Opportunity MeetingNuCerity New Opportunity Meeting
NuCerity New Opportunity Meeting
Carol Small
 
2 Pepsi Co
2 Pepsi Co2 Pepsi Co
Business Opportunity
Business OpportunityBusiness Opportunity
Business Opportunity
Chris Empey
 
Abb Ppt 9.9.08
Abb Ppt 9.9.08Abb Ppt 9.9.08
Abb Ppt 9.9.08
Shafer
 
Jeunesse Presentation
Jeunesse PresentationJeunesse Presentation
Jeunesse Presentation
Sean Conrad
 
Jeunesse Global Presentation
Jeunesse Global PresentationJeunesse Global Presentation
Jeunesse Global Presentation
Sean Conrad
 
Piper Jaffray 2018 US Fitness Industry Update
Piper Jaffray 2018 US Fitness Industry UpdatePiper Jaffray 2018 US Fitness Industry Update
Piper Jaffray 2018 US Fitness Industry Update
Bryan K. O'Rourke
 
Precision3 Opportunity Presentation
Precision3 Opportunity PresentationPrecision3 Opportunity Presentation
Precision3 Opportunity Presentation
Precision3 LLC
 
Max Gxl Comp Plan
Max Gxl Comp PlanMax Gxl Comp Plan
Max Gxl Comp Plan
vinjey21
 

Similar to Max1m 1230 042507 (20)

Freedom Plan 5[1]
Freedom Plan 5[1]Freedom Plan 5[1]
Freedom Plan 5[1]
 
Agel Presentation
Agel PresentationAgel Presentation
Agel Presentation
 
Agel Updated Abb Ppt 11 17 08
Agel Updated Abb Ppt 11 17 08Agel Updated Abb Ppt 11 17 08
Agel Updated Abb Ppt 11 17 08
 
Agel Business Briefing
Agel Business BriefingAgel Business Briefing
Agel Business Briefing
 
Abb Presentation
Abb PresentationAbb Presentation
Abb Presentation
 
New Company Launches
New Company LaunchesNew Company Launches
New Company Launches
 
Agel Presentation 20090521
Agel Presentation 20090521Agel Presentation 20090521
Agel Presentation 20090521
 
Traci's vs. new team elites ppt aug 2011
Traci's vs. new team elites ppt aug 2011 Traci's vs. new team elites ppt aug 2011
Traci's vs. new team elites ppt aug 2011
 
NuCERITY International Pre-Launch Opportunity
NuCERITY International Pre-Launch OpportunityNuCERITY International Pre-Launch Opportunity
NuCERITY International Pre-Launch Opportunity
 
Nucerity International Business Opportunity
Nucerity International  Business OpportunityNucerity International  Business Opportunity
Nucerity International Business Opportunity
 
NuCERITY International Pre-Launch Opportunity
NuCERITY International Pre-Launch OpportunityNuCERITY International Pre-Launch Opportunity
NuCERITY International Pre-Launch Opportunity
 
NuCerity New Opportunity Meeting
NuCerity New Opportunity MeetingNuCerity New Opportunity Meeting
NuCerity New Opportunity Meeting
 
2 Pepsi Co
2 Pepsi Co2 Pepsi Co
2 Pepsi Co
 
Business Opportunity
Business OpportunityBusiness Opportunity
Business Opportunity
 
Abb Ppt 9.9.08
Abb Ppt 9.9.08Abb Ppt 9.9.08
Abb Ppt 9.9.08
 
Jeunesse Presentation
Jeunesse PresentationJeunesse Presentation
Jeunesse Presentation
 
Jeunesse Global Presentation
Jeunesse Global PresentationJeunesse Global Presentation
Jeunesse Global Presentation
 
Piper Jaffray 2018 US Fitness Industry Update
Piper Jaffray 2018 US Fitness Industry UpdatePiper Jaffray 2018 US Fitness Industry Update
Piper Jaffray 2018 US Fitness Industry Update
 
Precision3 Opportunity Presentation
Precision3 Opportunity PresentationPrecision3 Opportunity Presentation
Precision3 Opportunity Presentation
 
Max Gxl Comp Plan
Max Gxl Comp PlanMax Gxl Comp Plan
Max Gxl Comp Plan
 

Recently uploaded

Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
rishi2789
 
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
FFragrant
 
Ketone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistryKetone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistry
Dhayanithi C
 
Top-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India ListTop-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India List
SwisschemDerma
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
LaniyaNasrink
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
walterHu5
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
taiba qazi
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
chiranthgowda16
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
Health Advances
 
THERAPEUTIC ANTISENSE MOLECULES .pptx
THERAPEUTIC ANTISENSE MOLECULES    .pptxTHERAPEUTIC ANTISENSE MOLECULES    .pptx
THERAPEUTIC ANTISENSE MOLECULES .pptx
70KRISHPATEL
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
suvadeepdas911
 
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachIntegrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Ayurveda ForAll
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
rishi2789
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
Tina Purnat
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
Jim Jacob Roy
 
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
bkling
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
NephroTube - Dr.Gawad
 
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...
rightmanforbloodline
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
reignlana06
 

Recently uploaded (20)

Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
 
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
 
Ketone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistryKetone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistry
 
Top-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India ListTop-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India List
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
 
THERAPEUTIC ANTISENSE MOLECULES .pptx
THERAPEUTIC ANTISENSE MOLECULES    .pptxTHERAPEUTIC ANTISENSE MOLECULES    .pptx
THERAPEUTIC ANTISENSE MOLECULES .pptx
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
 
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachIntegrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
 
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
 
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
 

Max1m 1230 042507

  • 1. Tom O’Connor Julia Walker Lauren Dusak Kristina Gentilozzi Kaitlin McQuade Frank Marallo Derek Szu-Tu Lauren Faga Brandon Miniman Sean Helmig Carolyn McCarthy Chuck Sgammato Mike Pattavina Angela Russo M ax1m I nnovations
  • 2.
  • 3.
  • 4.
  • 5.
  • 6.
  • 7.
  • 8.
  • 9.
  • 10. CM and Net Income Wholesale Price: $1.59 Cost: - $0.14 Contribution Margin: $1.45 Projected Net Income Contribution Margin Maxim Innovations
  • 11. Break Even Maxim Innovations
  • 12.
  • 13.
  • 14.
  • 15.
  • 16.
  • 17. Existings Products **** It is a proven fact that Vitamin B12’s absorption is inhibited by certain vitamins, including Vitamin C, 1 of the 10 essential vitamins found in Vitaball Purpose: Distribution: Target Market: Maxim Innovations Energy Seeking Adults! Children Sticks Gumballs Delivers Vitamin B12 to promotes the production of red blood cells, increased metabolism and more ENERGY Delivers 100% Recommended Daily Allowance of 10 essential vitamins Boost 12 Vitaball
  • 18. Vitamin B12 Absorption Through Tongue According to the article, Vitamin B12 Cobalamin , sublingual (under the tongue) delivery of Vitamin B12, such as through a gum or tablet form, is most effective. This method of delivery allows the for the quickest way for B12 to be absorbed straight into the bloodstream. Maxim Innovations
  • 19. Functional Gum Market “ Wrigley, Cadbury and Hershey all continue to take steps in new product development …. If a smaller company develops a functional gum type that is able to challenge the existing hierarchy of teeth whitening gums, it is likely that they would make an attractive target to one of these larger players.” Quote on www.gmid.euromonitor.com. Maxim Innovations
  • 20. Taste Preference Maxim Innovations Source: Euromonitor International estimates 10.00 10.00 10.00 Lemon  9.00 9.00 9.00 Apple  7.00 7.00 7.00 Juicy Fruit  6.00 6.00 6.00 Cinnamon  5.00 4.00 4.00 Wintergreen  4.00 5.00 5.00 Bubble Gum  3.00 3.00 3.00 Mint  2.00 2.00 2.00 Peppermint  1.00 1.00 1.00 Spearmint  2006 2005 2004 Rank Table 7 Leading Flavors for Gum 2004-2006
  • 21. Have you had your B12 today? Recommended Dietary Allowances for Vitamin B12 Source: www.ods.od.nih.gov Maxim Innovations 2.4 19+ 2.4 14-18 1.8 9-13 1.2 4-8 0.9 1-3 Allowance (μg/day) Age (years)
  • 22.
  • 23.
  • 24. Ad Cost per year Rate Base per year Men’s Fitness 668,360 6,500,000 Men’s Health 1,461,600 17,500,000 Women’s Health 834,756 7,500,000 Shape 1,202,640 19,200,000 Total $ 4,167,356 50,700,000 Yr 1 Sports Illustrated 2,222,755 23,400,000 Self 1,230,636 16,800,000 4,167,356 50,700,000 Total $ 7,620,747 90,900,000 Yr 2 Magazine Advertising Costs Maxim Innovations
  • 25.
  • 26. Year One: $4,294,377 Year Two: $7,767,665 Year Three: $8,136,182 Year Four: $8,494,800 Year Five: $8,494,800 Total Advertising Costs Per Year Maxim Innovations
  • 27. Valuation of Company Residual Value $16,093,533 NPV $9,093,533 Projected Sales Price $25,187,066 Maxim Innovations
  • 28. Break Even (10% increase best case) Maxim Innovations
  • 29. Projected Income (10% sales increase) NPV = $14,419,233 IRR = 38% Maxim Innovations
  • 30. Sales Figures (Expected) Maxim Innovations 305,772 552 46 5322 Total 19,944 72 6 277 Trader Joes 17,616 48 4 367 Bally 6,480 48 4 135 Sports Clubs 24,000 60 5 400 LA Fitness 25,536 48 4 532 Gold's Gym 8,592 48 4 179 World Gym 9,264 48 4 193 Whole Foods 33,000 60 5 550 Vitamin Works 9,600 60 5 160 Vitamin Shoppe 151,740 60 5 2529 GNC Stores Total # boxes # boxes/ yr # boxes / month # Stores YEAR 2008
  • 31.
  • 32.
  • 33.
  • 34. Taxes (Expected) Maxim Innovations $ 4,514,224 $ 3,423,476 $ 2,479,680 $ 913,079 $ (509,131) $ (773,755) $ - Tax Payable $ - $ - $ - $ 913,079 $ (509,131) $ (890,137) $ (773,755) Total NOL $ 4,514,224 $ 3,423,476 $ 2,479,680 $ 1,422,210 $ 381,006 $ - $ - Income Tax Expense $ - $ - $ - $ - $ - $ (116,382) $ (773,755) NOL $ 4,514,224 $ 3,423,476 $ 2,479,680 $ 1,422,210 $ 381,006 $ (116,382) $ (773,755) Tax Expense $ 13,277,129 $ 10,069,046 $ 7,293,175 $ 4,182,971 $ 1,120,606 $ (342,301) $ (2,275,749) Earnings before Taxes 2014 2013 2012 2011 2010 2009 2008
  • 35. Taxes (Worst Case) Maxim Innovations $ 3,634,959 $ 2,658,897 $ 1,306,256 $ (508,573) $ (1,376,741) $ (912,784) $ - Tax Pay $ - $ - $ 1,306,256 $ (508,573) $ (1,376,741) $ (1,376,741) $ (912,784) Total NOL $ 3,634,959 $ 2,658,897 $ 1,814,829 $ 868,168 $ - $ - $ - Income Tax Exp $ - $ - $ - $ - $ (36,083) $ (463,957) $ (912,784) NOL $ 3,634,959 $ 2,658,897 $ 1,814,829 $ 868,168 $ (36,083) $ (463,957) $ (912,784) Tax Exp $ 10,691,055 $ 7,820,286 $ 5,337,732 $ 2,553,435 $ (106,125) $ (1,364,578) $ (2,684,659) EBIT 2014 2013 2012 2011 2010 2009 2008
  • 36. Taxes (Best Case) Maxim Innovations $ 4,954,752 $ 3,806,205 $ 2,812,105 $ 1,641,947 $ (57,285) $ (646,835) $ - Tax Payable $ - $ - $ - $ 1,641,947 $ (57,285) $ (646,835) $ (704,240) Total NOL $ 4,954,752 $ 3,806,205 $ 2,812,105 $ 1,699,231 $ 589,551 $ 57,405 $ - Income Tax Expense $ - $ - $ - $ - $ - $ - $ (704,240) NOL $ 4,954,752 $ 3,806,205 $ 2,812,105 $ 1,699,231 $ 589,551 $ 57,405 $ (704,240) Tax Expense $ 14,572,800 $ 11,194,721 $ 8,270,897 $ 4,997,739 $ 1,733,972 $ 168,837 $ (2,071,293) Earnings before Taxes 2014 2013 2012 2011 2010 2009 2008